Aberrant splicing of the ATM gene associated with shortening of the intronic mononucleotide tract in human colon tumor cell lines: A novel mutation target of microsatellite instability

International Journal of Cancer

Volumn 86, Issue 2, 2000, Pages 262-268

  Ejima, Yosuke ^a,c   Yang, Lichun ^b   Sasaki, Masao S ^b  

^a PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Hiroshima Prefectural Coll Hlth Sci   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ATAXIA TELANGIECTASIA; COLON TUMOR; GENE DELETION; HUMAN; HUMAN CELL; INTRON; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR GENE; RNA SPLICING; T CELL LEUKEMIA;

CELL CYCLE PROTEINS; COLONIC NEOPLASMS; DNA PRIMERS; DNA-BINDING PROTEINS; GENE DELETION; HUMANS; INTRONS; MICROSATELLITE REPEATS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN-SERINE-THREONINE KINASES; RNA SPLICING; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0034028409     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000415)86:2<262::AID-IJC17>3.0.CO;2-I     Document Type: Article

References (27)

1. BOYER, J.C., UMAR, A., RISINGER, J.I., LIPFORD, J.R., KANE, M., YIN, S., BARRETT, C., KOLODNER, R.D. and KUNKEL, T.A., Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res., 55, 6063-6070 (1995).
2. BULLRICH, F., RASIO, D., KITADA, S., STAROSTIK, P., KIPPS, T., KEATING, M., ALBITAR, M., REED, J.C. and CROCE, C.M., ATM mutations in B-cell chronic leukemia. Cancer Res., 59, 24-27 (1999).
3. CHU, C.-S., TRAPNELL, B.C., CURRISTIN, S., CUTTING, G.R. and CRYSTAL, R.G., Genetic basis of variable exon 9 skipping in cystic tibrosis transmembrane conductance regulator mRNA. Nature (Genet.), 3, 151-156 (1993).
4. EJIMA, Y. and SASAKI, M.S., Mutations of the ATM gene detected in Japanese ataxia-telangiectasia patients: possible preponderance of the two founder mutations 4612del165 and 7883de15. Hum. Genet., 102, 403-408 (1998).
5. FITZGERALD, M.G., BEAN, J.M., HEDGE, S.R., UNSAL, H., MACDONALD, D.J., HARKIN, D.P., FINKELSTEIN, D.M., ISSELBACHER, K.J. and HABER, D.A., Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature (Genet.), 15, 307-310 (1997).
6. GILAD, S. and 22 OTHERS, Predominance of null mutations in ataxiatelangiectasia. Hum. mol. Genet., 5, 433-439 (1996).
7. HACIA, J.G., SUN, B., HUNT, N., EDGEMON, K., MOSBROOK, D., ROBBINS, C., FODOR, S.P.A., TAGLE, D.A. and COLLINS, F.S., Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays. Genome Res., 8, 1245-1258 (1999).
8. KOIKE, M., TAKEUCHI, S., PARK, S., HATTA, Y., YOKOTA, J., TSURUOKA, N. and KOEFFLER, H.P., Ovarian cancer: loss of heterozygosity frequently occurs in the ATM gene, but structural alterations do not occur in this gene. Oncology, 56, 160-163 (1999).
9. LAKEN, S.J. and 15 OTHERS, Familial colorectal cancer in Ashkenazim due to hypermutable tract in APC. Nature (Genet.), 17, 79-83 (1997).
10. LUO, L., LU, F., HART, S., FORONI, L., RABBANI, H., HAMMERSTRÖM, L., WEBSTER, A.D.B. and VORECHOVSKY, I., Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL. Cancer Res., 58, 2293-2297 (1998).
11. MALKHOSYAN, S., RAMPINO, N., YAMAMOTO, H. and PERUCHO, M., Frame-shift mutator mutations. Nature (Lond.), 382, 499-500 (1996).
12. MARKOWITZ, S., WANG, J., MYEROFF, L., PARSONS, R., SUN, L., LUTTERBAUGH, J., FAN, R.S., ZBOROWSKA, E., KINZLER, K.W., VOGELSTEIN, B., BRATTAIN, M. and WILSON, J.K.V., Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 268, 1336-1338 (1995).
13. PARSONS, R., MYEROFF, L.L., LIU, B., WILLSON, J.K.V., MARKOWITZ, S.D., KINZLER, K.W. and VOGELSTEIN, B., Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res., 55, 5548-5550 (1995),
14. RAMPINO, N., YAMAMOTO, H., IONOV, Y., LI, Y., SAWAI, H., REED, J.C. and PERUCHO, M., Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science, 275, 967-969 (1997).
15. RASIO, D., NEGRINI, M., MANETI, G., DRAGANI, T. and CROCE, C.M., Loss of heterozygosity at chromosome 1 1q in lung adenocarcinoma: identification of three independent regions. Cancer Res., 55, 3988-3991 (1995).
16. REID, T.W., ALBERT, D.M., RABSON, A.S., RUSSELL, P., CRAFT, J., CHU, E. W., TRALKA, T.S. and WILKOX, J.L., Characteristics of an established cell line of retinoblastoma. J. nat. Cancer Inst., 53, 347-360 (1974).
17. RUSSELL, J., WHELDON, E. and STANTON, P., Radioresistant variant derived from a human neuroblastoma cell line is less prone to radiation-induced apoptosis. Cancer Res., 55, 4915-4921 (1995).
18. SANDOVAL, N. and 16 OTHERS, Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum. mol. Genet., 8, 69-79 (1999).
19. SAVITSKY, K. and 29 OTHERS, A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science, 268, 1749-1753 (1995).
20. STANKOVIC, T., WEBER, P., STEWART, G., BEDENHAM, T., MURRAY, J., BYRD, P.J., MOSS, P.A. and TAYLOR, A.M.R., Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukemia. Lancet, 353, 26-29 (1999).
21. TAKENOSHITA, S., TANI, M., MOGI, A., NAGASHIMA, M., NAGAMICHI, Y., BENNETI, W.P., HAGIWARA, K., HARRIS, C.C. and YOKOTA, J., Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers. Carcinogenesis, 19, 803-807 (1998).
22. TELATAR, M. and 14 OTHERS, Ataxia-telangiectasia: identification and detection of founder-effect mutations in the ATM gene in ethnic populations. Amer. J. hum. Genet., 62, 86-97 (1998).
23. TRAN, H.T., KEEN, J.D., KRICKER, M., RESNICK, M.A. and GORDENIN, D.A., Hypermutability of homonucleotide runs in mismatch repair and DNA polymerase proofreading yeast mutants. Mol. cell. Biol., 17, 2859-2865 (1997).
24. VORECHOVSKY, I., LUO, L., DYER, M.J., CATOVSKY, D., AMLOT, P.L., YAXLEY, J.C., FORONI, L., HAMMERSTRÖM, L., WEBSTER, D.B. and YULLIE, M.A.R., Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nature (Genet.), 17, 96-99 (1997).
25. VORECHOVSKY, I., LUO, L., LINDBLOM, A., NEGRINI, M., WEBSTER, A.D.B., CROCE, C.M. and HAMMERSTRÖM, L., ATM mutations in cancer families. Cancer Res., 56, 4130-4133 (1996a).
26. VORECHOVSKY, I., RADIO, D., LUO, L., MONACO, C., HAMMERSTRÖM, L., WEBSTER, A.D.B., ZALOUDIK, J., BARBANTI-BRODANO, G., JAMES, M., RUSSO, G., CROCE, C.M. and NEGRINI, M., The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutations. Cancer Res., 56, 2726-2732 (1996b).
27. WAHA, A., STURNE, C., KESSELER, A., KOCH, A., KREYER, E., FIMMERS, R., WIESTLER, O.D., VON DEIMLING, A., KREBS, D. and SCHMUTZLER, R.K., Expression of the ATM gene is significantly reduced in sporadic breast carcinomas. Int. J. Cancer, 78, 306-309 (1998).